Monday, January 8th, 2018
As of January 8, 2018, most PAML direct clients in the Oregon market will be converted to LabCorp processes and systems. All stat testing requests will be handled thru LabCorp current processes, which includes using a local contracted stat testing partner. LabCorp is excited to share our enhanced capabilities with the Oregon healthcare community.Read More
Tuesday, December 26th, 2017
As of December 18, 2017, most PAML direct clients in the Idaho market will be converted to LabCorp processes and systems. LabCorp has begun a cooperative testing arrangement with a local laboratory to provide enhanced laboratory services to the greater Northern Idaho community and to focus on maintaining test quality, improving turnaround time and enhancing patient care.Read More
Thursday, May 4th, 2017
BURLINGTON, N.C., RENTON, WASH., ENGLEWOOD, COLO. – May 4, 2017 –LabCorp® (NYSE:LH) has completed the acquisition of Pathology Associates Medical Laboratories (PAML) from former owners Providence Health & Services (Providence) and Catholic Health Initiatives (CHI). PAML, based in Spokane, Washington, is one of the nation’s premier medical reference laboratories and a healthcare solutions company.Read More
Thursday, April 13th, 2017
SPOKANE, Washington (March 2, 2017) —Pathology Associates Medical Laboratories, LLC (PAML) has installed a cutting-edge automated line at their National Reference Laboratory (NRL), the first of its kind to be used in the United States.
Automated lines are instruments that process diagnostic samples from start to finish and are essential for efficient testing of specimens. Such automation is indispensable to the laboratory industry - especially in settings like Spokane where thousands of samples are processed each day.Read More
Saturday, February 25th, 2017
LabCorp to Acquire Pathology Associates Medical Laboratories from Providence Health & Services and Catholic Health Initiatives
BURLINGTON, N.C., RENTON, WASH., ENGLEWOOD, COLO. – (BUSINESS WIRE) – Feb. 23, 2017 –Read More
Friday, February 24th, 2017
Letter to PAML clients from President and CEO
Francisco R. Velazquez, M.D., S.M.
Dear Valued Client:
I am writing to inform you of an important announcement.
Laboratory Corporation of America (LabCorp) is purchasing Pathology Associates Medical Laboratories (PAML) and PAML's interest in several joint ventures. LabCorp will assume sole ownership once the transaction is complete.Read More
Wednesday, February 8th, 2017
SPOKANE, Washington (December 28, 2016) Dr. Francisco Velázquez, President and CEO of Pathology Associates Medical Laboratories, LLC (PAML), was asked to sit on the Executive Committee for Life Science Washington.Read More
PAML President and CEO to serve on University of Washinton School of Medicine-Gonzaga Regional Health Partnership Advisory Board
Wednesday, February 8th, 2017
SPOKANE, Washington (December 28, 2016) —Pathology Associates Medical Laboratories, LLC (PAML) President and CEO, Dr. Francisco Velázquez, has been appointed to the University of Washington School
of Medicine – Gonzaga Regional Health Partnership’s Spokane Advisory Board.
“It’s an honor to have been selected to serve on this board. Medical education, research, and progression have been a driving force in my career and I am looking forward to continuing to open dialogue and expand the industry,” said Dr. Velázquez of his newly appointed position.Read More
Francisco R. Velázquez, M.D., S.M. to speak on panel at WSU Health Policy and Administration Program
Friday, November 4th, 2016
SPOKANE, Washington (November 2, 2016) —Pathology Associates Medical Laboratories, LLC (PAML) President and Chief Executive Officer, Dr. Francisco R. Velázquez, was invited to participate in a panel discussing healthcare reform and population health at Washington State University’s (WSU) Riverpoint campus in Spokane, Washington on November 7, 2016.Read More